Valentina Albarani
Nessuna posizione attualmente
Profilo
Valentina Albarani worked as Director of Preclinical Research at Bone Therapeutics SA, Principal at BruCells NV, and Principal at German Cancer Research Center.
She holds a doctorate degree from the University of Cambridge.
Precedenti posizioni note di Valentina Albarani
| Società | Posizione | Fine |
|---|---|---|
German Cancer Research Center
 German Cancer Research Center Hospital/Nursing ManagementHealth Services German Cancer Research Center offers biomedical research services. It develops novel approaches to make tumor diagnosis more precise and for a treatment of cancer. The firm provides different research programs such as cell and tumor biology, functional and structural genomics, risk factors and prevention, tumor immunology, imaging and radio oncology, and translational cancer research. The company was founded in 1964 and is headquartered in Heidelberg, Germany. | Corporate Officer/Principal | - |
BruCells NV
 BruCells NV Pharmaceuticals: MajorHealth Technology BruCells NV develops therapeutic vaccines against cancer. The company was founded in 2001 and is headquartered in Brussels, Belgium. | Corporate Officer/Principal | - |
| BIOSENIC SA | Corporate Officer/Principal | - |
Formazione di Valentina Albarani
| University of Cambridge | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 3 |
|---|---|
Bone Therapeutics SA
 Bone Therapeutics SA Pharmaceuticals: MajorHealth Technology Bone Therapeutics SA is a cell therapy company, which engages in the regenerative therapy addressing for unmet medical needs in the field of bone diseases and orthopedics. Its products include Allob and JTA-004. The company was founded by Jacques Reymann on June 16, 2006 and is headquartered in Gosselies, Belgium. | Health Technology |
German Cancer Research Center
German Cancer Research Center Hospital/Nursing ManagementHealth Services German Cancer Research Center offers biomedical research services. It develops novel approaches to make tumor diagnosis more precise and for a treatment of cancer. The firm provides different research programs such as cell and tumor biology, functional and structural genomics, risk factors and prevention, tumor immunology, imaging and radio oncology, and translational cancer research. The company was founded in 1964 and is headquartered in Heidelberg, Germany. | Health Services |
BruCells NV
BruCells NV Pharmaceuticals: MajorHealth Technology BruCells NV develops therapeutic vaccines against cancer. The company was founded in 2001 and is headquartered in Brussels, Belgium. | Health Technology |
- Borsa valori
- Insiders
- Valentina Albarani
